thesis-toulmin
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
2
Q35212113-F93B5FD5-3C89-49A3-9887-420A52578090
Q35212113-F93B5FD5-3C89-49A3-9887-420A52578090
BestRank
Statement
http://www.wikidata.org/entity/statement/Q35212113-F93B5FD5-3C89-49A3-9887-420A52578090
Randomized phase Ib/II trial of rilotumumab or ganitumab with panitumumab versus panitumumab alone in patients with wild-type KRAS metastatic colorectal cancer.
P2860
Q35212113-F93B5FD5-3C89-49A3-9887-420A52578090
BestRank
Statement
http://www.wikidata.org/entity/statement/Q35212113-F93B5FD5-3C89-49A3-9887-420A52578090
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
470f5c91d127ecbd8202e89d1d5b2e9be2748f68
P2860
Randomized, phase II study of the insulin-like growth factor-1 receptor inhibitor IMC-A12, with or without cetuximab, in patients with cetuximab- or panitumumab-refractory metastatic colorectal cancer.